MedTrace Logo

Effect of Jaeumgeonbi-Tang on Chronic Subjective Dizziness

NCT05482828 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-10-10

No results posted yet for this study

Summary

The goal of this study is to assess the safety and efficacy of JGT (Jaeumgeonbi-Tang). A randomized, double-blind, parallel-group, placebo-controlled clinical trial was conducted and changes in symptoms and quality of life of the patients were evaluated.

Conditions

  • Chronic Subjective Dizziness

Interventions

DRUG

JGT (Jaeumgeonbi-Tang) tablet

JGT tablet (composed of 19 herbs), 24 g daily (single dose=8 g), t.i.d. for 28 days

DRUG

Placebo tablet

Corn starch tablet, 24 g daily (single dose=8 g), t.i.d. for 28 days

Sponsors & Collaborators

  • Korea Health Industry Development Institute

    lead OTHER_GOV

Principal Investigators

  • Yoo HoRyong, KMD, PhD · Daejeon University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-31
Primary Completion
2011-12-31
Completion
2013-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05482828 on ClinicalTrials.gov